Close

Avrobio Inc. (AVRO) PT Raised to $36 at Wedbush

Go back to Avrobio Inc. (AVRO) PT Raised to $36 at Wedbush

AVROBIO, Inc (AVRO) Prices 4.35M Share Common Offering at $23/Sh

February 13, 2020 5:47 AM EST

AVROBIO, Inc. (NASDAQ: AVRO), a leading clinical-stage gene therapy company, today announced the pricing of an underwritten public offering of 4,350,000 shares of its common stock at a public offering price of $23.00 per share. Gross proceeds from the underwritten public offering will total approximately $100 million, before deducting underwriting discounts and commissions and other... More

Avrobio Inc. (AVRO) PT Raised to $35 at Mizuho Securities

February 11, 2020 6:37 AM EST

Mizuho Securities analyst Difei Yang raised the price target on Avrobio Inc. (NASDAQ: AVRO) to $35.00 (from $28.00) while maintaining a Buy rating.... More